查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1328884

除霜系统的全球市场（包括按国家/地区分類的市场）

Thawing Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球除霜系统市场将达到 5.046 亿美元

在COVID-19后不断变化的商业环境中，预计2022年全球除霜系统市场规模为2.156亿美元，到2030年已修正为5.046亿美元，年复合成长率预计将增长11.2%。血液是本报告分析的细分市场之一，预计复合年复合成长率10.1%，到分析期结束时将达到 2.592 亿美元。考虑到大流行后持续的复苏，未来八年胚胎细分市场的年复合成长率已调整为 13.1%。

美国市场预计6370万美元，中国预计复合年增长率10.4%

预计 2022 年美国除霜系统市场规模将达到 6370 万美元。中国作为世界第二大经济体，预计到2030年市场规模将达到8570万美元，2022年至2030年分析期间年复合成长率为10.4%。其他值得注意的地域市场包括日本和加拿大，预计从 2022 年到 2030 年，这两个市场将分别增长 10.1% 和 9.5%。在欧洲，德国的年复合成长率预计约为 7.9%。

受访企业示例

  • Barkey GmbH & Co. KG
  • Biocision, LLC
  • Boekel Scientific, Inc.
  • Cardinal Health, Inc.
  • CytoTherm
  • GE Healthcare
  • Helmer Scientific
  • Sarstedt AG & Co.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

目录

第1章调查方法

第2章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和促进因素
  • 全球市场预测

第3章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 意大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第4章竞争

简介目录
Product Code: MCP15187

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Thawing Systems Market to Reach $504.6 Million by 2030

In the changed post COVID-19 business landscape, the global market for Thawing Systems estimated at US$215.6 Million in the year 2022, is projected to reach a revised size of US$504.6 Million by 2030, growing at aCAGR of 11.2% over the period 2022-2030. Blood, one of the segments analyzed in the report, is projected to record 10.1% CAGR and reach US$259.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Embryo segment is readjusted to a revised 13.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $63.7 Million, While China is Forecast to Grow at 10.4% CAGR

The Thawing Systems market in the U.S. is estimated at US$63.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$85.7 Million by the year 2030 trailing a CAGR of 10.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.1% and 9.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Select Competitors (Total 41 Featured) -

  • Barkey GmbH & Co. KG
  • Biocision, LLC
  • Boekel Scientific, Inc.
  • Cardinal Health, Inc.
  • CytoTherm
  • GE Healthcare
  • Helmer Scientific
  • Sarstedt AG & Co.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Thawing Systems - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Thawing Systems Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Thawing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 3: World 8-Year Perspective for Thawing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 5: World 8-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Embryo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 7: World 8-Year Perspective for Embryo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ovum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 9: World 8-Year Perspective for Ovum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Semen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 11: World 8-Year Perspective for Semen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 13: World 8-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 15: World 8-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Tissue Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 17: World 8-Year Perspective for Tissue Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 19: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 21: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • JAPAN
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Japan 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • CHINA
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 35: China 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 37: China 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • EUROPE
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Europe 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Thawing Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 41: Europe 8-Year Perspective for Thawing Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Europe 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • FRANCE
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: France 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 46: France Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 47: France 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • GERMANY
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Germany 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Germany 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • ITALY
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Italy 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Italy 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • UNITED KINGDOM
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 57: UK 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 58: UK Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 59: UK 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Rest of World 8-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Rest of World 8-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2023 & 2030

IV. COMPETITION